Related Experiment Video

Updated: May 18, 2026

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
16:49

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

[Hepatitis C virus F protein-mediated inhibition of hepatoma cell proliferation]

Fan Zhou1, Jiao Liu, Qing-mei Chen

  • 1Chongqing Medical University, Chongqing, China.

Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology
|September 14, 2012
PubMed
Abstract

Insights

The hepatitis C virus (HCV) F protein significantly inhibits the proliferation of liver cancer cells. This suggests the HCV F protein acts as a growth suppressor in infected hepatocytes.

Area of Science:

  • Hepatology and Virology
  • Molecular Biology

Context:

  • Hepatitis C virus (HCV) infection is a major cause of liver disease.
  • The biological functions of many viral proteins, including the HCV F protein, remain poorly understood.
  • Hepatocytes are the primary target cells for HCV infection.

Purpose:

  • To elucidate the biological role of the hepatitis C virus (HCV)-encoded F protein within hepatocytes.
  • To investigate the effect of stable HCV F gene and protein expression on hepatoma cell lines.

Summary:

  • The full-length HCV F gene was successfully amplified and cloned into a plasmid.
  • Hepatoma cell lines (Huh7 and SMMC7721) stably expressing the F protein exhibited significantly reduced proliferation rates.
  • Cell cycle analysis revealed a decrease in S-phase distribution in F protein-expressing cells, indicating cell cycle arrest.

Impact:

  • The findings indicate that the HCV F protein possesses growth-inhibitory properties.
  • This study suggests a potential role for the HCV F protein as a suppressor of infected cell proliferation.
  • Understanding the function of the HCV F protein could offer new insights into HCV pathogenesis and potential therapeutic targets.

More Related Videos

A Protocol for Analyzing Hepatitis C Virus Replication13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Immunofluorescence to Monitor the Cellular Uptake of Human Lactoferrin and its Associated Antiviral Activity Against the Hepatitis C Virus06:28

Immunofluorescence to Monitor the Cellular Uptake of Human Lactoferrin and its Associated Antiviral Activity Against the Hepatitis C Virus

Published on: October 1, 2015

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...